News & Analysis as of

Weight-Loss Products › Hatch-Waxman

Morgan Lewis

Does GLP-1 Compounding Foretell Patent Enforcement Outside the Hatch-Waxman Framework?

Morgan Lewis on

Recent developments involving compounded GLP-1 products have renewed questions about compounded drugs as a potential quasi-generic competitor. This LawFlash examines the regulatory limits on drug compounding and highlights...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide